Covered in this report
The report covers the present scenario and the growth prospects of the global metabolic disorders therapeutics market for 2016-2020 . To calculate the market size , the report considers the revenue generated from the sales of branded , generic , and off-label drugs used for the treatment of various metabolic disorders including diabetes , obesity , lysosomal storage diseases , and hypercholesterolemia .
The market is divided into the following segments based on geography :
• Americas
• APAC
• EMEA
Related reports by Radiant Insights : http :// www . radiantinsights . com / catalog / healthcare
Global Metabolic Disorders Therapeutics Market 2016-2020 , has been prepared based on an indepth market analysis with inputs from industry experts . The report covers the market landscape and its growth prospects over the coming years . The report also includes a discussion of the key vendors operating in this market .
Key vendors
• Novo Nordisk
• Sanofi
• Merck
• AstraZeneca
• Eli Lilly
Other prominent vendors
• AbbVie
• Actelion Pharmaceuticals
• Adocia
• Aegerion Pharmaceuticals
• Akros Pharma
Follow Us :